Should Ventilator-Associated Events become a Quality Indicator for ICUs?

References

1. 1.↵
   1. Magill SS,
   2. Klompas M,
   3. Balk R,
   4. Burns SM,
   5. Deutschman CS,
   6. Diekema D,
   7. et al

   . Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med 2013;41(11):2467–2475.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lilly CM,
   2. Ellison RT 3rd.

   . Quality measures for critically ill patients: where does ventilator-associated condition fit in? Chest 2013;144(5):1429–1430.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Schurink CA,
   2. Van Nieuwenhoven CA,
   3. Jacobs JA,
   4. Rozenberg-Arska M,
   5. Joore HC,
   6. Buskens E,
   7. et al

   . Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med 2004;30(2):217–224.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Klompas M

   . Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38(3):237–239.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Stevens JP,
   2. Kachniarz B,
   3. Wright SB,
   4. Gillis J,
   5. Talmor D,
   6. Clardy P,
   7. Howell MD

   . When policy gets it right: variability in U.S. hospitals' diagnosis of ventilator-associated pneumonia. Crit Care Med 2014;42(3):497–503.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Klein Klouwenberg PM,
   2. Ong DS,
   3. Bos LD,
   4. de Beer FM,
   5. van Hooijdonk RT,
   6. Huson MA,
   7. et al

   . Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013;41(10):2373–2378.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Ego A,
   2. Preiser JC,
   3. Vincent JL

   . Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. Chest 2015;147(2):347–355.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Petersen IS,
   2. Aru A,
   3. Skødt V,
   4. Behrendt N,
   5. Bols B,
   6. Kiss K,
   7. Simonsen K

   . Evaluation of pneumonia diagnosis in intensive care patients. Scand J Infect Dis 1999;31(3):299–303.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Klompas M,
   2. Kulldorff M,
   3. Platt R

   . Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 2008;46(9):1443–1446.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Muscedere JG,
    2. Day A,
    3. Heyland DK

    . Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis 2010;51(Suppl 1):S120–S125.

    OpenUrlAbstract/FREE Full Text
11. 11.
    1. Nguile-Makao M,
    2. Zahar JR,
    3. Français A,
    4. Tabah A,
    5. Garrouste-Orgeas M,
    6. Allaouchiche B,
    7. et al

    . Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010;36(5):781–789.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Melsen WG,
    2. Rovers MM,
    3. Groenwold RH,
    4. Bergmans DC,
    5. Camus C,
    6. Bauer TT,
    7. et al

    . Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013;13(8):665–671.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Klompas M,
    2. Li L

    . Beyond pneumonia: improving care for ventilated patients. Lancet Infect Dis 2013;13(8):640–641.

    OpenUrlPubMed
14. 14.↵
    1. Klompas M

    . Eight initiatives that misleadingly lower ventilator-associated pneumonia rates. Am J Infect Control 2012;40(5):408–410.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Klompas M

    . The paradox of ventilator-associated pneumonia prevention measures. Crit Care 2009;13(5):315.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Kollef MH,
    2. Afessa B,
    3. Anzueto A,
    4. Veremakis C,
    5. Kerr KM,
    6. Margolis BD,
    7. et al

    . Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300(7):805–813.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.
    1. Klompas M

    . Silver-coated endotracheal tubes and patient outcomes in ventilator-associated pneumonia. JAMA 2008;300(22):2605; author reply 2605–2606.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Klompas M,
    2. Speck K,
    3. Howell MD,
    4. Greene LR,
    5. Berenholtz SM

    . Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014;174(5):751–761.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Price R,
    2. MacLennan G,
    3. Glen J

    . Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014;348:g2197.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Klompas M

    . Does this patient have ventilator-associated pneumonia? JAMA 2007;297(14):1583–1593.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Tejerina E,
    2. Esteban A,
    3. Fernández-Segoviano P,
    4. Frutos-Vivar F,
    5. Aramburu J,
    6. Ballesteros D,
    7. Rodríguez-Barbero JM

    . Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings. J Crit Care 2010;25(1):62–68.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Klompas M,
    2. Khan Y,
    3. Kleinman K,
    4. Evans RS,
    5. Lloyd JF,
    6. Stevenson K,
    7. et al

    . Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011;6(3):e18062.

    OpenUrlCrossRefPubMed
23. 23.
    1. Klompas M,
    2. Magill S,
    3. Robicsek A,
    4. Strymish JM,
    5. Kleinman K,
    6. Evans RS,
    7. et al

    . Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012;40(12):3154–3161.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.
    1. Prospero E,
    2. Illuminati D,
    3. Marigliano A,
    4. Pelaia P,
    5. Munch C,
    6. Barbadoro P,
    7. D'Errico MM

    . Learning from Galileo: ventilator-associated pneumonia surveillance. Am J Respir Crit Care Med 2012;186(12):1308–1309.

    OpenUrlPubMed
25. 25.↵
    1. Hayashi Y,
    2. Morisawa K,
    3. Klompas M,
    4. Jones M,
    5. Bandeshe H,
    6. Boots R,
    7. et al

    . Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013;56(4):471–477.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Muscedere J,
    2. Sinuff T,
    3. Heyland DK,
    4. Dodek PM,
    5. Keenan SP,
    6. Wood G,
    7. et al

    . The clinical impact and preventability of ventilator-associated conditions in critically ill mechanically ventilated patients. Chest 2013;144(5):1453–1460.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Klompas M,
    2. Kleinman K,
    3. Murphy MV

    . Descriptive epidemiology and attributable morbidity of ventilator-associated events. Infect Control Hosp Epidemiol 2014;35(5):502–510.

    OpenUrlPubMed
28. 28.↵
    1. Klein Klouwenberg PM,
    2. van Mourik MS,
    3. Ong DS,
    4. Horn J,
    5. Schultz MJ,
    6. Cremer OL,
    7. et al

    . Electronic implementation of a novel surveillance paradigm for ventilator-associated events: feasibility and validation. Am J Respir Crit Care Med 2014;189(8):947–955.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Lilly CM,
    2. Landry KE,
    3. Sood RN,
    4. Dunnington CH,
    5. Ellison RT 3rd.,
    6. Bagley PH,
    7. et al

    . Prevalence and test characteristics of National Health Safety Network ventilator-associated events. Crit Care Med 2014;42:2019–2028.

    OpenUrlPubMed
30. 30.↵
    1. Boyer AF,
    2. Schoenberg N,
    3. Babcock H,
    4. McMullen KM,
    5. Micek ST,
    6. Kollef MH

    . A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest 2015;147(1):68–81.

    OpenUrlPubMed
31. 31.↵
    1. Stevens JP,
    2. Silva G,
    3. Gillis J,
    4. Novack V,
    5. Talmor D,
    6. Klompas M,
    7. Howell MD

    . Automated surveillance for ventilator-associated events. Chest 2014;146(6):1612–1618.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Bouadma L,
    2. Sonneville R,
    3. Garrouste-Orgeas M,
    4. Darmon M,
    5. Souweine B,
    6. Voiriot G,
    7. et al

    . Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 2015;43(9):1798–1806.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Resetar E,
    2. McMullen KM,
    3. Russo AJ,
    4. Doherty JA,
    5. Gase KA,
    6. Woeltje KF

    . Development, implementation and use of electronic surveillance for ventilator-associated events (VAE) in adults. AMIA Annu Symp Proc 2014;2014:1010–1017.

    OpenUrlPubMed
34. 34.↵
    1. Lewis SC,
    2. Li L,
    3. Murphy MV,
    4. Klompas M

    , CDC Prevention Epicenters. Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med 2014;42(8):1839–1848.

    OpenUrlPubMed
35. 35.↵
    1. Ogbu OC,
    2. Martin GS,
    3. Sevransky JE,
    4. Murphy DJ

    . High tidal volumes are independently associated with development of a ventilator-associated condition in the ICU. Am J Respir Crit Care Med 2015;191:A3117.

    OpenUrl
36. 36.↵
    1. Sinuff T,
    2. Muscedere J,
    3. Cook DJ,
    4. Dodek PM,
    5. Anderson W,
    6. Keenan SP,
    7. et al

    . Implementation of clinical practice guidelines for ventilator-associated pneumonia: a multicenter prospective study. Crit Care Med 2013;41(1):15–23.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Klompas M,
    2. Anderson D,
    3. Trick W,
    4. Babcock H,
    5. Kerlin MP,
    6. Li L,
    7. et al

    . The preventability of ventilator-associated events: the CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med 2015;191(3):292–301.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Mekontso Dessap A,
    2. Katsahian S,
    3. Roche-Campo F,
    4. Varet H,
    5. Kouatchet A,
    6. Tomicic V,
    7. et al

    . Ventilator-associated pneumonia during weaning from mechanical ventilation: role of fluid management. Chest 2014;146(1):58–65.

    OpenUrlPubMed
39. 39.↵
    1. Klompas M

    . Complications of mechanical ventilation: the CDC's new surveillance paradigm. N Engl J Med 2013;368(16):1472–1475.

    OpenUrlPubMed
40. 40.↵
    1. Klompas M

    . Ventilator-associated events surveillance: a patient safety opportunity. Curr Opin Crit Care 2013;19(5):424–431.

    OpenUrlPubMed
41. 41.↵
    1. Klompas M

    . Potential strategies to prevent ventilator-associated events. Am J Respir Crit Care Med 2015;192(12):1420–1430.

    OpenUrlPubMed
42. 42.↵
    1. Barr J,
    2. Fraser GL,
    3. Puntillo K,
    4. Ely EW,
    5. Gélinas C,
    6. Dasta JF,
    7. et al

    . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263–306.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.
    1. Halpern SD,
    2. Becker D,
    3. Curtis JR,
    4. Fowler R,
    5. Hyzy R,
    6. Kaplan LJ,
    7. et al

    . An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Crit Care Med policy statement: the Choosing Wisely Top 5 list in Crit Care Med Am J Respir Crit Care Med 2014;190(7):818–826.
44. 44.↵
    1. Morandi A,
    2. Brummel NE,
    3. Ely EW

    . Sedation, delirium and mechanical ventilation: the “ABCDE” approach. Curr Opin Crit Care 2011;17(1):43–49.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Chang HC,
    2. Kung SC,
    3. Wang CM,
    4. Liu WL

    . Discordance between novel and traditional surveillance paradigm of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2014;35(9):1195–1196.

    OpenUrlPubMed
46. 46.↵
    1. Stoeppel CM,
    2. Eriksson EA,
    3. Hawkins K,
    4. Eastman A,
    5. Wolf S,
    6. Minei J,
    7. Minshall CT

    . Applicability of the National Healthcare Safety Network's surveillance definition of ventilator-associated events in the surgical intensive care unit: a 1-year review. J Trauma Acute Care Surg 2014;77(6):934–937.

    OpenUrlPubMed
47. 47.↵
    1. Nussenblatt V,
    2. Avdic E,
    3. Berenholtz S,
    4. Daugherty E,
    5. Hadhazy E,
    6. Lipsett PA,
    7. et al

    . Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care units. Infect Control Hosp Epidemiol 2014;35(3):278–284.

    OpenUrlPubMed
48. 48.↵
    1. Anderson DJ,
    2. Chen LF,
    3. Sexton DJ,
    4. Kaye KS

    . Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting. Infect Control Hosp Epidemiol 2008;29(10):941–946.

    OpenUrlCrossRefPubMedWeb of Science
49. 49.↵
    1. Niederman MS,
    2. Nair GB

    . Managing ventilator complications in a “VACuum” of data. Chest 2015;147(1):5–6.

    OpenUrlPubMed
50. 50.↵
    1. Helmerhorst HJ,
    2. Roos-Blom MJ,
    3. van Westerloo DJ,
    4. de Jonge E

    . Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, metaanalysis, and meta-regression of cohort studies. Crit Care Med 2015;43(7):1508–1519.

    OpenUrlPubMed
51. 51.↵
    1. Shorr AF,
    2. Zilberberg MD

    . Nature (and the ICU) abhors a VACuum. Chest 2012;142(6):1365–1366.

    OpenUrlPubMed
52. 52.↵
    1. Piriyapatsom A,
    2. Lin H,
    3. Pirrone M,
    4. De Pascale G,
    5. Corona De Lapuerta J,
    6. Bittner EA,
    7. et al

    . Evaluation of the infection-related ventilator-associated events algorithm for ventilator-associated pneumonia surveillance in a trauma population. Respir Care 2016;61(3):269–276.

    OpenUrlAbstract/FREE Full Text
53. 53.↵
    1. Salluh JI,
    2. Soares M

    . ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care 2014;20(5):557–565.

    OpenUrlPubMed
54. 54.↵
    1. Hoste EA,
    2. Clermont G,
    3. Kersten A,
    4. Venkataraman R,
    5. Angus DC,
    6. De Bacquer D,
    7. Kellum JA

    . RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006;10(3):R73.

    OpenUrlCrossRefPubMed
55. 55.↵
    1. Zimmerman JE,
    2. Kramer AA,
    3. McNair DS,
    4. Malila FM

    . Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006;34(5):1297–1310.

    OpenUrlCrossRefPubMedWeb of Science
56. 56.↵
    1. Bagshaw SM,
    2. George C,
    3. Bellomo R

    , ANZICS Database Management Committee. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23(5):1569–1574.

    OpenUrlAbstract/FREE Full Text
57. 57.↵
    1. Giard M,
    2. Lepape A,
    3. Allaouchiche B,
    4. Guerin C,
    5. Lehot JJ,
    6. Robert MO,
    7. et al

    . Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors. J Crit Care 2008;23(1):27–33.

    OpenUrlCrossRefPubMedWeb of Science